oseltamivir has been researched along with Hematologic Malignancies in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonfanti, C; Cattaneo, C; Corbellini, S; Perandin, F; Piccinelli, G; Pollara, CP; Rossi, G; Tomasi, DD | 1 |
| Avni-Shemer, Y; Ben-Harush, M; Ben-Shimol, S; Dotan, A; Fruchtman, Y; Givon-Lavi, N; Greenberg, D; Kapelushnik, J; Leibovitz, E | 1 |
| Almirall, J; Blanquer, J; Canadell, L; Díaz, E; Grau, S; Martín-Loeches, I; Olona, M; Rodriguez, A; Sureda, F; Trefler, S; Yebenes, JC | 1 |
| Chan, PA; Chapin, K; Connell, NT; Gabonay, AM; Larkin, JM; LaRosa, SP; Mermel, L; Westley, B | 1 |
| Adams-Huet, B; Ardura, MI; Brock, E; Cost, C; Siegel, JD | 1 |
| Amayiri, N; Madanat, F | 1 |
| Altuntaş, F; Arda, K; Arıbaş, B; Arslan, H; Demiriz, I; Erbay, C; Koçubaba, S; Özdilekcan, C; Tekgündüz, E; Tetik, A; Yüksel, MK | 1 |
| Boas, LS; da Rocha, IF; Dulley, FL; Machado, CM; Mendes, AV; Pannuti, CS; Santos, MF; Sturaro, D | 1 |
| Boas, LS; da Rocha, IF; Dulley, FL; Machado, CM; Mendes, AV; Pannuti, CS; Sturaro, D | 1 |
| Boeckh, M; Corey, L; Englund, JA; Nichols, WG; Peck, AJ; Varley, C; Vu, D | 1 |
1 trial(s) available for oseltamivir and Hematologic Malignancies
| Article | Year |
|---|---|
Use of Oseltamivir to control influenza complications after bone marrow transplantation.
Topics: Acetamides; Alphainfluenzavirus; Antiviral Agents; Betainfluenzavirus; Bone Marrow Transplantation; Follow-Up Studies; Hematologic Neoplasms; Humans; Influenza, Human; Nasal Lavage Fluid; Oseltamivir; Premedication; Seasons; Treatment Outcome | 2004 |
9 other study(ies) available for oseltamivir and Hematologic Malignancies
| Article | Year |
|---|---|
Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.
Topics: Adult; Aged; Antiviral Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Viral; Female; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Retrospective Studies | 2013 |
Influenza A/H1N1 in pediatric oncology patients.
Topics: Anti-Bacterial Agents; Antiviral Agents; Child; Female; Follow-Up Studies; Hematologic Neoplasms; Hospitalization; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units, Pediatric; Male; Nasal Lavage Fluid; Oseltamivir; Pandemics; Polymerase Chain Reaction; Prognosis; Prospective Studies | 2014 |
Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
Topics: Adult; Aged; Antiviral Agents; APACHE; Cohort Studies; Comorbidity; Critical Care; Drug Utilization; Female; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Medication Adherence; Middle Aged; Oseltamivir; Pandemics; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Registries; Spain; Survival Rate | 2015 |
Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient.
Topics: Adult; Animals; Antiviral Agents; Drug Resistance, Viral; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; United States | 2010 |
2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.
Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Neoplasms; Oseltamivir; Pandemics; Retrospective Studies; Treatment Outcome | 2011 |
Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection.
Topics: Adolescent; Child; Child, Preschool; Fever; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Oseltamivir; Pandemics; Retrospective Studies; Time Factors; Young Adult | 2011 |
Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Retrospective Studies | 2010 |
Low mortality rates related to respiratory virus infections after bone marrow transplantation.
Topics: Acetamides; Aerosols; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Fluorescent Antibody Technique, Indirect; Hematologic Neoplasms; Humans; Influenza, Human; Oseltamivir; Paramyxoviridae Infections; Postoperative Complications; Respirovirus Infections; Ribavirin; Transplantation, Autologous; Transplantation, Homologous; Virus Shedding | 2003 |
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Case-Control Studies; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Oseltamivir; Probability; Reference Values; Retrospective Studies; Risk Assessment; Treatment Outcome | 2007 |